• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Viral Receptor-Binding Site Antibodies with Diverse Germline Origins

tetano

Editor, Senior Moderator
Cell. 2015 May 6. pii: S0092-8674(15)00445-6. doi: 10.1016/j.cell.2015.04.028. [Epub ahead of print]
[h=1]Viral Receptor-Binding Site Antibodies with Diverse Germline Origins.[/h] Schmidt AG[SUP]1[/SUP], Therkelsen MD[SUP]1[/SUP], Stewart S[SUP]2[/SUP], Kepler TB[SUP]3[/SUP], Liao HX[SUP]4[/SUP], Moody MA[SUP]4[/SUP], Haynes BF[SUP]4[/SUP], Harrison SC[SUP]5[/SUP].
[h=3]Author information[/h]

[h=3]Abstract[/h] Vaccines for rapidly evolving pathogens will confer lasting immunity if they elicit antibodies recognizing conserved epitopes, such as a receptor-binding site (RBS). From characteristics of an influenza-virus RBS-directed antibody, we devised a signature motif to search for similar antibodies. We identified, from three vaccinees, over 100 candidates encoded by 11 different V[SUB]H[/SUB] genes. Crystal structures show that antibodies in this class engage the hemagglutinin RBS and mimic binding of the receptor, sialic acid, by supplying a critical dipeptide on their projecting, heavy-chain third complementarity determining region. They share contacts with conserved, receptor-binding residues but contact different residues on the RBS periphery, limiting the likelihood of viral escape when several such antibodies are present. These data show that related modes of RBS recognition can arise from different germline origins and mature through diverse affinity maturation pathways. Immunogens focused on an RBS-directed response will thus have a broad range of B cell targets.
Copyright ? 2015 Elsevier Inc. All rights reserved.


PMID: 25959776 [PubMed - as supplied by publisher]
 
Back
Top Bottom